Literature DB >> 23868224

Don't market stem-cell products ahead of proof.

Paolo Bianco1.   

Abstract

Mesh：

Year:  2013        PMID： 23868224     DOI： 10.1038/499255a

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  4 in total

1.  Regulation of cell-based therapies in Europe: current challenges and emerging issues.

Authors:  Alessandro Blasimme; Emmanuelle Rial-Sebbag
Journal:  Stem Cells Dev       Date:  2013-12       Impact factor: 3.272

Review 2.  Stem cell therapy: from evidence-based medicine to emotion-based medicine? The long Italian way for a scientific regulation.

Authors:  Paola Frati; Giacomo Frati; Matteo Gulino; Gianluca Montanari Vergallo; Alessandro Di Luca; Vittorio Fineschi
Journal:  Stem Cell Res Ther       Date:  2013-10-11       Impact factor: 6.832

3.  Whole-genome sequencing identifies genetic variances in culture-expanded human mesenchymal stem cells.

Authors:  Jun Cai; Xuexia Miao; Yueying Li; Cory Smith; Kitman Tsang; Linzhao Cheng; Qian-Fei Wang
Journal:  Stem Cell Reports       Date:  2014-06-26       Impact factor: 7.765

Review 4.  Strategies for improving adipose-derived stem cells for tissue regeneration.

Authors:  Xin Yuan; Li Li; Haofan Liu; Jing Luo; Yongchao Zhao; Cheng Pan; Xue Zhang; Yuwen Chen; Maling Gou
Journal:  Burns Trauma       Date:  2022-08-16
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.